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Abstract
Background: with ageing populations and increasing exposure to risk factors for chronic diseases, the prevalence of chronic
disease multimorbidity is rising globally. There is little evidence on the determinants of multimorbidity and its impact on
healthcare utilisation and health status in Europe.
Methods: we used cross-sectional data from the Survey of Health, Ageing and Retirement in Europe (SHARE) in 2011–12,
which included nationally representative samples of persons aged 50 and older from 16 European nations. Negative binomial
and logistic regression models were used to assess the association between number of chronic diseases and healthcare utilisa-
tion, self-perceived health, depression and reduction of functional capacity.
Results: overall, 37.3% of participants reported multimorbidity; the lowest prevalence was in Switzerland (24.7%), the highest in
Hungary (51.0%). The likelihood of having multimorbidity increased substantially with age. Number of chronic conditions was asso-
ciated with greater healthcare utilisation in both primary (regression coefﬁcient for medical doctor visits = 0.29, 95% CI = 0.27–
0.30) and secondary setting (adjusted odds ratio (AOR) for having any hospitalisation in the last year = 1.49, 95% CI = 1.42–1.55) in
all countries analysed. Number of chronic diseases was associated with fair/poor health status (AOR 2.13, 95% CI = 2.03–2.24),
being depressed (AOR 1.48, 95% CI = 1.42–1.54) and reduced functional capacity (AOR 2.12, 95% CI = 2.02–2.22).
Conclusion: multimorbidity is associated with greater healthcare utilisation, worse self-reported health status, depression and
reduced functional capacity in European countries. European health systems should prioritise improving the management of patients
with multimorbidity to improve their health status and increase healthcare efﬁciency.
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Introduction
Chronic conditions are the leading cause of global disease
burden worldwide [1].With population ageing and increasing
exposure to risk factors, the prevalence of multimorbidity,
deﬁned as persons with two or more co-existing chronic con-
ditions [2, 3], is likely to grow in many settings.
Emerging evidence has found that patients with multi-
morbidity have higher health service utilisation, healthcare ex-
penditure and poorer health outcomes [4–7]. Multimorbidity
might be considered as major source of healthcare inefﬁciency
with higher risk of avoidable inpatient admission, suboptimal
disease management, inadequate treatment and communica-
tion barriers [2, 7–11].
Despite the growing prevalence of multimorbidity in
Europe, few published studies have examined its impact
in European health systems [8, 12–14], and none of these
studies have undertaken cross-country comparisons. The
aim of this study is to examine correlates of multimorbidity
and its impact on healthcare utilisation, self-reported health
status, mental health and functional capacity using nationally
representative samples from multiple countries in Europe.
431
 at U
niversita di N
apoli on A
ugust 11, 2016
http://ageing.oxfordjournals.org/
D
ow
nloaded from
 
Methods
Sample and data
We used cross-sectional data from the Survey of Health, Ageing
and Retirement in Europe (SHARE), which was conducted
during 2011–12 (Wave 4). The data collected national repre-
sentative samples of individuals aged 50 and over in 16
European countries: Austria, Belgium, Switzerland, Germany,
Denmark, Spain, France, Italy, Netherlands, Sweden, Czech
Republic, Poland, Estonia, Hungary, Portugal and Slovenia.
The data contain individuals’ information on their socio-
demographic characteristics, health status and healthcare
utilisation.
Variables
Our main variable of interest was the number of coexistent
chronic diseases (CDs) reported by each respondent. We counted
the number of CDs for each respondent and deﬁned those
with multimorbidity as the presence of two or more of
chronic diseases.
Respondents were asked about their healthcare utilisation
in both primary and secondary care, including (i) number of
medical doctor visits, deﬁned as the sum of general practi-
tioner (GP), emergency room and outpatient visits during
the last year, (ii) whether or not been hospitalised in the past
year, (iii) the number of hospitalisations in the past year and
(iv) total nights at the hospital in the past year.
We also considered the following outcomes: (i) self-rated
health coded in two groups (a) ‘excellent’, ‘very good’ and
‘good’ health and (b) ‘fair’ or ‘poor’ health; (ii) depression,
measured through the Euro-D classiﬁcation [15] and (iii) re-
duction of functional capacity, categorised as reduced/not
reduced, through the GALI scale [16]. Deﬁnition of each of
the outcome variables can be found in the Supplementary
data, Appendix S2, available in Age and Ageing online.
We included the following covariates in the analyses:
age, gender, whether the respondents lived alone, education,
household income and employment status.
Statistical analysis
We used multiple logistic regression analysis to determine
socioeconomic and demographic correlates of multimorbid-
ity (binary variable). We assessed the association between
number of CDs (count variable) and binary outcomes using
logistic regression models. These binary outcomes included
any hospitalisation, fair/poor self-perceived health status,
depression and reduction of functional capacity. We ran
negative binomial models to assess the association between
number of CDs and number of medical doctor visits,
number and length of hospitalisations. All the models
adjusted for covariates listed above. A detailed version of the
research methods is available online (Supplementary data,
Appendix S1, available in Age and Ageing online).
Results
We analysed information from 56,427 respondents
(Supplementary data, Appendix S2, available in Age and
Ageing online). The median age was 66 years (IQR 58–73),
55.9% were female, 84.1% had at least secondary level or
above of education and 57.6% were retired.
The mean number of CDs was 1.37 (95% CI = 1.35–
1.38, Supplementary data, Appendix S4, available in Age and
Ageing online). The crude prevalence of multimorbidity
was 37.3%, and this percentage increased from 22.7%
for persons aged 50–59 to 52.8% for persons aged 70 and
over (Figure 1). Respondents from Switzerland had the
Figure 1. Prevalence of multimorbidity by age category in 16 European countries. AT, Austria; DE, Germany; SE, Sweden; NL,
Netherlands; SP, Spain; IT, Italy; FR, France; DK, Denmark; CH, Switzerland; BE, Belgium; CZ, Czech Republic; PL, Poland; HU,
Hungary; PT, Portugal; SL, Slovenia; EE, Estonia; EU POOLED, Europe.
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lowest number of CDs (mean = 1.2, 95% CI = 1.2–1.3)
with those from Hungary having the highest (mean = 2.2,
95% CI = 2.1–2.2). The prevalence of multimorbidity
ranged from 24.7% in Switzerland to 51.0% in Hungary.
High blood pressure was the most prevalent condition
(42.8%), followed by arthritis/rheumatism (26.4%) and heart
problems (15.0%).
The likelihood of having multimorbidity increased substan-
tially with age (AOR= 1.36, 95% CI = 1.17–1.59 for 60–69
years group; AOR= 2.79, 95% CI = 2.34–3.32 for the 70+
years group, compared with 50–59 years group), and this asso-
ciation was found to be statistically signiﬁcant in all countries
except in Hungary and Denmark. Participants with higher
levels of education were less likely to have multimorbidity
(primary completed: AOR= 1.52, 95%CI = 1.32–1.75; no
formal education: AOR= 1.55, 95% CI = 1.26–1.91, com-
pared with those who completed at least a second level of edu-
cation). Those in the most afﬂuent quintile (ﬁfth quintile) were
less likely to have multimorbidity (ﬁfth quintile: AOR= 0.64,
95% CI = 0.54–0.75, compared with ﬁrst quintile), a ﬁnding
that was consistent within countries (Supplementary data,
Appendix S5, available inAge and Ageing online).
Increasing number of CDs was associated with a
higher number of medical doctor visits (coeff = 0.29, 95%
CI = 0.27–0.30, Figure 2). The mean number of medical
doctor visits annually increased from 4.8 in persons without
any CD to 9.9 for persons with multimorbidity. The positive
association between increasing number of CDs and primary
care utilisation was found in all countries, and this association
was found to be the strongest in Italy (coeff = 0.35, 95%
CI = 0.31–0.40).
Increasing number of CDs was also associated with
higher secondary care utilisation (Figure 2, Supplementary
data, Appendix S6, available in Age and Ageing online).
Increasing number of CDs was signiﬁcantly associated with a
higher likelihood of being hospitalised (AOR = 1.49, 95%
CI = 1.42–1.55), increased number of hospitalisations (coeff
= 0.35, 95% CI = 0.31–0.40) and a longer length of stay
(coeff = 0.49, 95% CI = 0.43–0.55). The association between
increasing number of CDs and secondary care utilisation was
found consistently across all countries.
Increasing number of CDs was associated with a higher
likelihood of reporting self-perceived fair/poor health status
(AOR= 2.13, 95% CI = 2.03–2.24), feeling depressed
(AOR= 1.48, 95% CI = 1.42–1.54) and to have reduced
functional capacity (AOR = 2.12, 95% CI = 2.02–2.22). This
association was found consistently across all countries and
was strongest in countries such as Portugal and Hungary
and weakest in countries such as Belgium and Switzerland
(Figure 2).
Discussion
We found that multimorbidity was highly prevalent (37%)
among older people in European countries. The variation in
prevalence within countries might reﬂect undiagnosed CDs
Figure 2. Association between number of CDs and healthcare utilisation, self-perceived health, depression and functional capacity.
Primary care utilisation deﬁned by the number of medical doctor visits, and secondary care utilisation deﬁned by the number of hos-
pitalisations. Regression coefﬁcients and AOR are adjusted for age, gender, number of people living in the same household, resi-
dence, educational level and employment status. All the regression coefﬁcients and AOR values were found statistically signiﬁcant.
AT, Austria; DE, Germany; SE, Sweden; NL, Netherlands; SP, Spain; IT, Italy; FR, France; DK, Denmark; CH, Switzerland; BE,
Belgium; CZ, Czech Republic; PL, Poland; HU, Hungary; PT, Portugal; SL, Slovenia; EE, Estonia; EU, Pooled data.
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and underlying population characteristics of each country.
We found a strong association between multimorbidity and
increasing age as well as level of education, employment
status and household income. An increasing number of CDs
was associated with higher healthcare utilisation in both
primary and secondary care settings. An increasing number
of CDs was also associated with worse self-perceived health,
reduced functional capacity and depression.
The strong association between increasing number of
CDs and increasing levels of healthcare utilisation in European
countries is consistent with recent studies conducted in both
developed and developing countries [6, 8, 12, 17–20] which
have highlighted the impact on secondary care utilisation
predominantly. Patients with multimorbidity can often have
complications during a hospital stay, and the subsequent in-
tensiﬁcation of care and coordinated approach needed might
impact the length of stay substantially.
Our ﬁndings showing that people with physical multimor-
bidity are more likely to be depressed in European countries
are in line with a recent Scottish study [4]. The strong asso-
ciation between multimorbidity and reduced functional
capacity is also in line with ﬁndings from a recent Canadian
study highlighting that these two conditions are strongly
interrelated [21].
Strength and limitations
According to our knowledge, this is the ﬁrst study to
examine the prevalence, correlates and impacts of chronic
disease multimorbidity using a large and nationally represen-
tative data in Europe. Limitations of the study include the
use of self-reported measures of chronic disease and health-
care utilisation which may underestimate their prevalence,
particularly for older persons and those from lower socio-
economic and educational background who may be more
likely to under-report [22, 23]. Prevalence of the study
outcomes might also be underestimated, because patients ad-
mitted to the hospital or with severe illness by the time the
survey was conducted might not have been able to partici-
pate. Furthermore, the SHARE questionnaire did not ask
about all diseases typically included in clinical database
studies [24]. By deﬁning multimorbidity as simple count of
CDs, our analysis weighted all diseases equally, although the
effect of multimorbidity on individuals can vary with com-
bination and severity of CDs [14]. Further studies looking at
the impact of CD co-morbidity among some of the most
common chronic conditions are warranted.
Policy implications
Our ﬁndings provide further evidence for policies and
targeted interventions to tackle the growing burden of multi-
morbidity in Europe. The strong association between health-
care utilisation and number of chronic diseases can be used
to populate forecasting models to predict future burden of
the CDs. The forecasting models can further assess the
potential impact of preventive policies on CDs and the eco-
nomic consequences of these policies [25].
Furthermore, considering that clinical management is still
largely focused on single diseases, our ﬁndings support the
idea that more focus should be placed on how to best treat
patients with multimorbidity who need a continuous, coordi-
nated and comprehensive approaches to their care [24, 26].
Improvement of the primary care system would contribute
to reductions in population risk factors for multimorbidity
and may contribute to reduce avoidable hospital admissions
[8–11, 27]. European health systems should prioritise im-
proving the management of patients with multimorbidity to
improve health outcomes, increase healthcare efﬁciency and
contain costs.
Key points
• First cross-national study to examine the prevalence, correlates
and impact of chronic disease multimorbidity in Europe.
• Multimorbidity is highly prevalent and consistently associated
with increased primary and secondary care utilisation.
• People with multimorbidity are more likely to have worse
self-perceived health, depression and reduced functional
capacity.
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